80.61996658206405, BRIEF-Volition Files Patent For Nu.Q(Tm) Covid-19 Triage Test And Commences Proof Of Concept Studies April 23 (Reuters) - VolitionRX Ltd: * VOLITION FILES PATENT FOR NU.Q(TM) COVID-19 TRIAGE TEST AND COMMENCES PROOF OF CONCEPT STUDIES * VOLITIONRX -WORKING WITH COLLABORATORS TO INVESTIGATE IF EXISTING NU.Q(TM) EPIGENETIC ASSAYS CAN PREDICT WHICH PATIENTS WITH COVID-19 ARE MOST AT RISK Source text for Eikon: Further company coverage:
2.313094282581283, BRIEF-Nu Skin Enterprises Q1 Earnings Per Share $0.64 April 26 (Reuters) - NU Skin Enterprises Inc: * NU SKIN ENTERPRISES REPORTS STRONG FIRST-QUARTER RESULTS AND INCREASES ANNUAL GUIDANCE * Q1 EARNINGS PER SHARE VIEW $0.69 -- THOMSON REUTERS I/B/E/S * FY2018 EARNINGS PER SHARE VIEW $3.61 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:
5.521959149054289," BRIEF-Nu Skin Enterprises Enters Into A Credit Agreement That Provides For A $400 Million Term Loan Facility April 23 (Reuters) - NU Skin Enterprises Inc: * NU SKIN ENTERPRISES SAYS ON APRIL 18, 2018 CO ENTERED INTO A CREDIT AGREEMENT THAT PROVIDES FOR A $400 MILLION TERM LOAN FACILITY - SEC FILING * NU SKIN ENTERPRISES INC - CREDIT AGREEMENT ALSO PROVIDES FOR A $350 MILLION REVOLVING CREDIT FACILITY EACH WITH A TERM OF FIVE YEARS Source text for Eikon: (bit.ly/2HmJK6B) Further company coverage:"
